Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
investing
2
×
life sciences
2
×
national blog main
national top stories
new york blog main
new york top stories
acute myeloid leukemia
alx oncology
antisense oligonucleotide
autoimmune diseases
benzodiazepines
berkeley lights
biogen
biotech ipos
blackstone group
blackstone life sciences
boston
cancer drugs
cancer immunotherapy
cd47
chronic kidney disease
columbia university
david goldstein
deals
deerfield healthcare technology acquisitions
deerfield management company
depression
epi4k
epilepsy
essential tremor
europe blog main
europe top stories
fda
immunotherapy
kidney disease
kiran reddy
What
new
2
×
research
2
×
aims
arrival
backed
biotech
cause
ceo
companies
days
drugs
epilepsy
genes
genetic
hasn’t
industry
ipo
ipos
life
links
marcio
market
medicines
momentum
mutations
neuro
praxis
precision
raised
science
slowed
souza
stop
street
summer’s
turn
wall
week
welcomed
Language
unset
Current search:
research
×
new
×
" life sciences "
×
investing
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs